Kemin Industries
1
1
0.02
1
- Areas of investment
Summary
Kemin Industries is the famous Corporate Investor, which was founded in 1961. The leading representative office of defined Corporate Investor is situated in the Des Moines. The fund was located in North America if to be more exact in United States.
Among the most popular portfolio startups of the fund, we may highlight Aptimmune. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Biopharma.
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the Kemin Industries, startups are often financed by The Yield Lab, St. Louis Arch Angels, Missouri Technology Corporation.
The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Rounds per year
- 0.02
- Investments by industry
- Biotechnology (1)
- Health Diagnostics (1)
- Test and Measurement (1)
- Health Care (1)
- Biopharma (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.